Acute myelogenous leukemia

Current Problems in Pediatric and Adolescent Health Care

Volumn 32, Issue 2, 2002, Pages 50-58

  Aquino, Victor M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; MYELOABLATIVE AGENT; RETINOIC ACID; ALLOPURINOL; AMINOGLYCOSIDE; ANTHRACYCLINE; ANTIBIOTIC AGENT; BUSULFAN; CEPHALOSPORIN DERIVATIVE; CYCLOPHOSPHAMIDE; HEPARIN; PENICILLIN G; THYMOCYTE ANTIBODY; TIOGUANINE; URATE OXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLEEDING; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER REGRESSION; CANCER RELAPSE; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; FEVER; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INFECTION; LEUKOSTASIS; LUNG INFILTRATE; PLEURA EFFUSION; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; SIDE EFFECT; TRISOMY 21; TUMOR LYSIS SYNDROME; WEIGHT GAIN; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DRUG EFFICACY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS; HYDRATION; HYPERURICEMIA; LEUKAPHERESIS; LYMPHOPROLIFERATIVE DISEASE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 23744439412     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1067/mps.2002.121791     Document Type: Article

References (34)

1. Kramer S, Meadows AT, Jarrett P, et al. Incidence of childhood cancer: experience of a decade in a population based registry. J Natl Cancer Inst 1983;70:49-55.
2. Smith MA, Gloecker Ries LA, Gurney JG, et al. Leukemia. In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JG, Bunin GR, editors. Cancer incidence and survival among children and adolescents. Bethesda (MD): National Cancer Institute, SEER Program; 1999. p. 17-34.
3. Weinstein HJ. Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome. Clin Haematol 1978;7:147-54.
4. Bhatia S, Neglia JP. Epidemiology of childhood acute myelogenous leukemia. J Pediatr Hematol Oncol 1995;17:94-100.
5. Robinson LL, Nesbit ME, Sather HN, et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from the Children Cancer Study Group. J Pediatr 1984;195:235-42.
6. Fong C, Brodeur GM. Down's syndrome outcome and leukemia: epidemiology, cytogenetics, and mechanism of leukemogenesis. Cancer Genet Cytogenet 1987;28:55-76.
7. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophylotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;321:136-42.
8. Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlation in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325-45.
9. Kaldor JM, Day NE, Clarke EA, et al. Leukemia following Hodgkin's disease. N Engl J Med 1990;322:7-13.
10. Bennett JM, Canovsky D, Daniel MT. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American- British Cooperative Group. Ann Intern Med 1985;103:626-9.
11. Raimondi SC, Chang MN, Ravindranath Y, et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical and characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999;94:3707-16.
12. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998;92:2322-33.
13. Choi SI, Simone JV. Acute nonlymphocytic leukemia in 171 children. Med Pediatr Oncol 1976;2:119-46.
14. Warrell RP, De The H, Wang ZY, et al. Acute promyelocytic leukemia. N Engl J Med 1993;329:177-89.
15. Homans AC, Verissimo AM, Vlacha V. Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol 1994;15:392-9.
16. Zipursky A, Poon A, Doyle J. Hematologic and oncologic disorders in Down syndrome. In: Lott IT, McCoy EE, editors. Down syndrome: advances in medical care. New York: Wiley-Liss; 1992. p. 93-101.
17. Lange BJ. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol 2000;110:512-24.
18. Lange BJ, Kobrinsky N, Barnard DR, et al. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group studies 2861 and 2891. Blood 1999;91:608-15.
19. Ravindranath Y, Abella E, Krischer JP, et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML study 8498. Blood 1992;80:2210-4.
20. Taub JW, Huang X, Matherly LH, et al. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood 1999;94:1393-400.
21. Woods WG, Kobrinsky N, Buckley JD, et al. Time-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 1996;87:4979-89.
22. Barbui T, Finazzi G, Falanga A. The impact of All-transretinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1998;91:3093-102.
23. Pizzo P. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
24. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051-62.
25. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group. Blood 2001;97:56-62.
26. Ravindranath Y, Yeager AM, Chang MN, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 1996;334:1428-34.
27. Stevens RF, Hann IM, Wheatley K, et al. Marked improvement in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. Br J Haematol 1998;101:130-40.
28. Gorin NC. Autologous stem cell transplantation in acute myelogenous leukemia. Blood 1998;92:1073-90.
29. Rowley JD, Golomb HM, Dougherty C. 15/17 Translocation: a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1977;1:549-50.
30. Larsen RA, Kondo K, Vadiman JW, et al. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 1984;76:827-41.
31. Tallman MS, Andersen JW, Schiffer CA, et al. All-transretinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337:1021-8.
32. Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-200.
33. Bahl GV, Lacayo NJ, Brophy N, et al. Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. J Clin Oncol 2000;18:1867-75.
34. Sievers E. Targeted immunotherapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates. Cancer Chemother Pharmacol 2000;46:S18-22.